Keel Point’s Shattuck Labs STTK Stock Holding History

Keel Point’s Portfolio STTK Stock Details STTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,270	Closed	-$52.1K	–	550
2025 Q4	$52.1K	Sell	14,270 -31,903	-69%	-$76.1K	﹤0.01%	533
2025 Q3	$110K	Buy	+46,173	New	+$56.5K	0.01%	513

Other funds holding STTK

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

NCM

NEXTBio Capital Management Menlo Park, California $215M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CEI

Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Keel Point's STTK Position: Q1 2026 in Review

Keel Point sold out of Shattuck Labs (STTK) in Q1 2026, closing a stake of 14,270 shares — an estimated $52.1K sold.

Keel Point first reported a position in STTK in Q3 2025 and held it in 2 quarters. The position peaked at $110K in Q3 2025. 84 funds tracked by Wall St. Rank hold STTK as of Q1 2026.

Keel Point reported no remaining Shattuck Labs position as of Q1 2026 after selling out during the quarter.
Keel Point sold 14,270 Shattuck Labs shares in Q1 2026, an estimated $52.1K.
Keel Point first reported a position in Shattuck Labs in Q3 2025 and held it in 2 quarters.
Keel Point's Shattuck Labs position peaked at $110K in Q3 2025.
84 funds tracked by Wall St. Rank held Shattuck Labs as of Q1 2026.

Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.